Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials
Publication
, Conference
Armstrong, AJ; Liu, VYT; Selvaraju, RR; Chen, E; Simko, J; DeVries, S; Sartor, AO; Sandler, HM; Mohamad, O; Esteva, A; Tran, PT; Spratt, DE ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J., Liu, V. Y. T., Selvaraju, R. R., Chen, E., Simko, J., DeVries, S., … Nguyen, P. L. (2023). Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).
Armstrong, Andrew J., Vinnie Y. T. Liu, Ramprasaath R. Selvaraju, Emmalyn Chen, Jeffry Simko, Sandy DeVries, A Oliver Sartor, et al. “Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
Armstrong AJ, Liu VYT, Selvaraju RR, Chen E, Simko J, DeVries S, et al. Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.
Armstrong, Andrew J., et al. “Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.
Armstrong AJ, Liu VYT, Selvaraju RR, Chen E, Simko J, DeVries S, Sartor AO, Sandler HM, Mohamad O, Esteva A, Tran PT, Spratt DE, Carson JH, Peters CA, Gore E, Lee SP, Monson JM, Rodgers JP, Feng FY, Nguyen PL. Development and validation of an AI-derived digital pathology-based biomarker to predict benefit of long-term androgen deprivation therapy with radiotherapy in men with localized high-risk prostate cancer across multiple phase III NRG/RTOG trials. JOURNAL OF CLINICAL ONCOLOGY. 2023.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences